A transient and low-populated protein-folding intermediate at atomic resolution
DM Korzhnev, TL Religa, W Banachewicz, AR Fersht, LE Kay
Science (New York, N.Y.)
(2010)
329
Refolding the Engrailed Homeodomain: Structural Basis for the Accumulation of a Folding Intermediate
ME McCully, DAC Beck, AR Fersht, V Daggett
Biophys J
(2010)
99
The human peripheral subunit-binding domain folds rapidly while overcoming repulsive Coulomb forces
E Arbely, H Neuweiler, TD Sharpe, CM Johnson, AR Fersht
Protein Sci
(2010)
19
Highest paraoxonase turnover rate found in a bacterial phosphotriesterase variant
L Briseño-Roa, Z Oliynyk, CM Timperley, AD Griffiths, AR Fersht
Protein Engineering Design and Selection
(2010)
24
S100 proteins interact with the N‐terminal domain of MDM2
J van Dieck, JK Lum, DP Teufel, AR Fersht
FEBS letters
(2010)
584
Mapping the physical and functional interactions between the tumor suppressors p53 and BRCA2.
S Rajagopalan, A Andreeva, TJ Rutherford, AR Fersht
Proc Natl Acad Sci U S A
(2010)
107
Transdisciplinary EU science institute needs funds urgently
JW Vasbinder, B Andersson, WB Arthur, M Boasson, R de Boer, JP Changeux, E Domingo, M Eigen, A Fersht, D Frenkel, M Rees, T Groen, R Huber, T Hunt, J Holland, R May, E Norrby, P Nijkamp, JM Lehn, R Rabbinge, M Scheffer, P Schuster, I Serageldin, J Stuip, J de Vries, W van Vierssen, R Willems
Nature
(2010)
463
The tumor suppressor p53: from structures to drug discovery.
AC Joerger, AR Fersht
Cold Spring Harbor Perspectives in Biology
(2010)
2
Molecular basis of S100 proteins interacting with the p53 homologs p63 and p73.
J van Dieck, T Brandt, DP Teufel, DB Veprintsev, AC Joerger, AR Fersht
Oncogene
(2010)
29
Engineering a two-helix bundle protein for folding studies
CA Dodson, N Ferguson, TJ Rutherford, CM Johnson, AR Fersht
Protein Engineering Design and Selection
(2010)
23
Toward the rational design of p53-stabilizing drugs: probing the surface of the oncogenic Y220C mutant.
N Basse, JL Kaar, G Settanni, AC Joerger, TJ Rutherford, AR Fersht
Chem Biol
(2010)
17
Reply to Campos et al.: Direct observation versus ambiguous kinetics and thermodynamics
F Huang, L Ying, H Neuweiler, AR Fersht
Proceedings of the National Academy of Sciences
(2009)
106
Multiple conformations of full-length p53 detected with single-molecule fluorescence resonance energy transfer.
F Huang, S Rajagopalan, G Settanni, RJ Marsh, DA Armoogum, N Nicolaou, AJ Bain, E Lerner, E Haas, L Ying, AR Fersht
Proceedings of the National Academy of Sciences of the United States of America
(2009)
106
Awakening guardian angels: drugging the p53 pathway
CJ Brown, S Lain, CS Verma, AR Fersht, DP Lane
Nature reviews. Cancer
(2009)
9
Mechanistic differences in the transcriptional activation of p53 by 14-3-3 isoforms.
S Rajagopalan, RS Sade, FM Townsley, AR Fersht
Nucleic Acids Res
(2009)
38
Direct observation of ultrafast folding and denatured state dynamics in single protein molecules
H Neuweiler, CM Johnson, AR Fersht
Proceedings of the National Academy of Sciences
(2009)
106
Structural evolution of p53, p63, and p73: Implication for heterotetramer formation
AC Joerger, S Rajagopalan, E Natan, DB Veprintsev, CV Robinson, AR Fersht
Proc Natl Acad Sci U S A
(2009)
106
Posttranslational Modifications Affect the Interaction of S100 Proteins with Tumor Suppressor p53
J van Dieck, DP Teufel, AM Jaulent, MR Fernandez-Fernandez, TJ Rutherford, A Wyslouch-Cieszynska, AR Fersht
Journal of Molecular Biology
(2009)
394
Direct observation of barrier-limited folding of BBL by single-molecule fluorescence resonance energy transfer.
F Huang, L Ying, AR Fersht
Proceedings of the National Academy of Sciences of the United States of America
(2009)
106
Biophysical characterizations of human mitochondrial transcription factor A and its binding to tumor suppressor p53
TS Wong, S Rajagopalan, SM Freund, TJ Rutherford, A Andreeva, FM Townsley, M Petrovich, AR Fersht
Nucleic Acids Research
(2009)
37